News from us and our partners

Tags

Topics

0 results

News
17 September, 2024
Arzeda secures $38M in oversubscribed funding round to advance protein design commercialization efforts
News
16 September, 2024
AAVantgarde announces first patient dosed with AAVB-081 in FIH Phase 1/2 LUCE-1 study for retinitis pigmentosa related to USH1B
News
12 September, 2024
F2G announces $100 million financing to advance late-stage development and commercialization of novel antifungal drug candidate Olorofim in the US
News
12 September, 2024
Novameat raises €17.4M oversubscribed Series A round led by Sofinnova Partners and Forbion
News
12 September, 2024
Genespire appoints Karen Aiach-Pignet as Chief Executive Officer
News
10 September, 2024
Sofinnova Partners appoints Karl Naegler as Partner
News
9 September, 2024
AAVantgarde appoints Dr. Jayashree Sahni as Chief Medical Officer
News
4 September, 2024
HEPTA Medical secures €5.7 million Series A, led by BPI France, to advance minimally invasive lung cancer treatment
News
2 September, 2024
Asahi Kasei completes the recommended public cash offer and becomes the owner of 93.30 per cent of all shares in Calliditas
News
2 September, 2024
Biotalys receives approval for large-scale demonstration trials of EVOCA in the Netherlands
News
29 August, 2024
AFYREN announces signing of new commercial contract with US nutraceutical maker
News
27 August, 2024
HighLife receives ISO 13485 certification of its quality management system
News
7 August, 2024
Mediar Therapeutics initiates second clinical program in portfolio of novel first-in-class antibodies designed to halt fibrosis
News
2 August, 2024
Video: Sofinnova Partners 2024 annual general meeting
News
1 August, 2024
NodThera announces appointment of Greg Chow as Chief Financial and Business Officer
News
25 July, 2024
Micropep raises $29m in Series B funding and unveils Krisalix, its proprietary discovery platform

Arzeda secures $38M in oversubscribed funding round to advance protein design commercialization efforts

AAVantgarde announces first patient dosed with AAVB-081 in FIH Phase 1/2 LUCE-1 study for retinitis pigmentosa related to USH1B

F2G announces $100 million financing to advance late-stage development and commercialization of novel antifungal drug candidate Olorofim in the US

Novameat raises €17.4M oversubscribed Series A round led by Sofinnova Partners and Forbion

Genespire appoints Karen Aiach-Pignet as Chief Executive Officer

Sofinnova Partners appoints Karl Naegler as Partner

AAVantgarde appoints Dr. Jayashree Sahni as Chief Medical Officer

HEPTA Medical secures €5.7 million Series A, led by BPI France, to advance minimally invasive lung cancer treatment

Asahi Kasei completes the recommended public cash offer and becomes the owner of 93.30 per cent of all shares in Calliditas

Biotalys receives approval for large-scale demonstration trials of EVOCA in the Netherlands

AFYREN announces signing of new commercial contract with US nutraceutical maker

HighLife receives ISO 13485 certification of its quality management system

Mediar Therapeutics initiates second clinical program in portfolio of novel first-in-class antibodies designed to halt fibrosis

Video: Sofinnova Partners 2024 annual general meeting

NodThera announces appointment of Greg Chow as Chief Financial and Business Officer

Micropep raises $29m in Series B funding and unveils Krisalix, its proprietary discovery platform